News | January 04, 2023
Themis Medicare launches Lenzetto for treatment of menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
To create leading company developing medicines targeting metalloenzymes
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Having a healthy gut is key as it permits the body to build a stronger immune system
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Cipla and Ethris partner for the development of mRNA-based therapies
All claims against the company in the litigation have now been dismissed.
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Subscribe To Our Newsletter & Stay Updated
